Cargando…

Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer

BACKGROUND: Lipid metabolic reprogramming in colon cancer shows a potential impact on tumor immune microenvironment and is associated with response to immunotherapy. Therefore, this study aimed to develop a lipid metabolism-related prognostic risk score (LMrisk) to provide new biomarkers and combina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lilong, Mo, Min, Chen, Xuehan, Chao, Dongchen, Zhang, Yufan, Chen, Xuewei, Wang, Yang, Zhang, Nan, He, Nan, Yuan, Xi, Chen, Honglei, Yang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100168/ https://www.ncbi.nlm.nih.gov/pubmed/37055842 http://dx.doi.org/10.1186/s13046-023-02647-8

Ejemplares similares

Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages
por: Chen, Yaxin, et al.
Publicado: (2022)

Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response
por: Zhang, Bomiao, et al.
Publicado: (2023)

Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer
por: Cao, Lichao, et al.
Publicado: (2022)

A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
por: Wu, Xiaocong, et al.
Publicado: (2023)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
por: Xu, Jin, et al.
Publicado: (2022)

Association between CYP24A1 polymorphisms and the risk of colonic polyps and colon cancer in a Chinese population
por: Chen, Xue-Qi, et al.
Publicado: (2017)

COVID-19: immunopathogenesis and Immunotherapeutics
por: Yang, Li, et al.
Publicado: (2020)

Lipid Metabolic-Related Signature CYP19A1 is a Potential Biomarker for Prognosis and Immune Cell Infiltration in Gastric Cancer
por: Wang, Nan, et al.
Publicado: (2022)

Integrated Analysis of Immune Infiltration Features for Cervical Carcinoma and Their Associated Immunotherapeutic Responses
por: Kang, Yanan, et al.
Publicado: (2021)

Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA
por: Wang, Jinju, et al.
Publicado: (2022)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD
por: Dong, Penggang, et al.
Publicado: (2023)

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
por: Wu, Yucai, et al.
Publicado: (2020)

Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
por: Li, Qi, et al.
Publicado: (2023)

Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis
por: Chen, Tianli, et al.
Publicado: (2021)

The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer
por: Xu, Xiao, et al.
Publicado: (2022)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Expression Patterns of Necroptosis-Related Genes: Predicting Prognosis and Immunotherapeutic Effects in Cutaneous Melanoma
por: Dong, Dong, et al.
Publicado: (2022)

Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
por: Xu, Jun, et al.
Publicado: (2023)

Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer
por: Kong, Xiaoyu, et al.
Publicado: (2023)

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
por: Zheng, Xingyu, et al.
Publicado: (2023)

Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma
por: Chi, Xiaohan, et al.
Publicado: (2022)

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
por: Liu, Shuangqing, et al.
Publicado: (2023)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications
por: Xu, Feng, et al.
Publicado: (2020)

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
por: Xue, Chen, et al.
Publicado: (2022)

Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm
por: Chen, Siteng, et al.
Publicado: (2022)

Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer
por: Ghione, Silvia, et al.
Publicado: (2022)

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity
por: Wu, Yanlin, et al.
Publicado: (2023)

Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade
por: Fang, Tianxu, et al.
Publicado: (2023)

Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
por: Guo, Liang, et al.
Publicado: (2020)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer
por: Zhang, Heng-Chun, et al.
Publicado: (2022)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
por: Pang, Zhaofei, et al.
Publicado: (2019)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qbkvuodn3qleb1djtmbpiee2f